🔗 Share this article The State of Texas Attorney General Sues Tylenol Manufacturers Over Autism Assertions Ken Paxton, who supports former President Trump who is running for US Senate, alleged pharmaceutical manufacturers of concealing potential dangers of Tylenol The top legal official in Texas Ken Paxton is taking legal action against the producers of acetaminophen, claiming the firms hid safety concerns that the drug created to children's cognitive development. The court filing arrives thirty days after Former President Trump promoted an unsubstantiated connection between consuming Tylenol - alternatively called acetaminophen - during pregnancy and autism in offspring. The attorney general is taking legal action against J&J, which once produced the drug, the sole analgesic recommended for expectant mothers, and the current manufacturer, which now manufacturers it. In a official comment, he claimed they "betrayed America by gaining financially from discomfort and promoting medication regardless of the risks." Kenvue states there is lacking scientific proof tying acetaminophen to autism spectrum disorder. "These corporations deceived for years, deliberately risking countless individuals to boost earnings," the attorney general, a Republican, said. The manufacturer said in a statement that it was "deeply concerned by the spread of false claims on the reliability of paracetamol and the potential impact that could have on the welfare of US mothers and children." On its official site, the company also mentioned it had "consistently assessed the relevant science and there is no credible data that indicates a established connection between taking paracetamol and autism." Organizations acting on behalf of doctors and health professionals agree. The American College of Obstetricians and Gynecologists has declared paracetamol - the primary component in acetaminophen - is one of the few options for women during pregnancy to address pain and elevated temperature, which can present serious health risks if not addressed. "In more than two decades of studies on the use of paracetamol in gestation, not a single reputable study has definitively established that the use of acetaminophen in any trimester of gestation leads to neurological conditions in offspring," the group said. The court filing mentions current declarations from the Trump administration in claiming the drug is potentially dangerous. In recent weeks, the former president generated worry from medical authorities when he told pregnant women to "struggle intensely" not to consume acetaminophen when sick. Federal regulators then released a statement that physicians should consider limiting the consumption of Tylenol, while also mentioning that "a proven link" between the drug and autism in young ones has not been established. Health Secretary Robert F Kennedy Jr, who manages the FDA, had pledged in April to conduct "extensive scientific investigation" that would establish the source of autism spectrum disorder in a short period. But authorities advised that identifying a unique factor of autism - believed by scientists to be the result of a intricate combination of inherited and surrounding conditions - would be difficult. Autism spectrum disorder is a category of lifelong neurodivergence and condition that influences how people experience and engage with the world, and is recognized using doctors' observations. In his lawsuit, the attorney general - who supports Trump who is seeking the Senate - claims Kenvue and Johnson & Johnson "willfully ignored and attempted to silence the evidence" around paracetamol and autism. This legal action attempts to require the companies "eliminate any marketing or advertising" that states acetaminophen is reliable for expectant mothers. The Texas lawsuit parallels the grievances of a collection of guardians of young ones with autism and attention deficit hyperactivity disorder who filed suit against the makers of acetaminophen in 2022. A federal judge threw out the legal action, stating studies from the family's specialists was lacking definitive proof.